T-Cells Can Predict Mesothelioma Treatment Success
Mesothelioma patients whose T-cell counts bounce back quickly after a round of chemotherapy have a better chance of survival. They are…
Mesothelioma Now Covered by Zadroga Act
First responders and others who have contracted malignant mesothelioma because of their exposure to asbestos during the 9/11 attacks in New York…
Surgery | Treatments | Updates
Implants May Help Mesothelioma Surgery Patients
Mesothelioma patients who undergo surgery for their cancer may benefit from new biological implants to reconstruct their chest wall. Malignant pleural…
Inhaling Mesothelioma Drug Soon Ready for Patient Trials
Mesothelioma patients may eventually be inhaling their treatment medications instead of receiving them intravenously if current research in Scotland goes according…
New Tools Help Pathologists Make Mesothelioma Diagnosis
Pathologists may be able to do a better job of diagnosing mesothelioma in the lab, thanks to a new set of tools…
Monoclonal Antibody a ‘Novel Treatment’ for Mesothelioma?
A drug currently used to treat colorectal cancer and some types of head and neck cancer may also offer a…
Mesothelioma Risk High if Raised Near Asbestos
There’s more evidence that exposure to asbestos early in life increases the risk of mesothelioma and a host of other cancers. A…
Mesothelioma Patients Lack Psychosocial Support
Most newly diagnosed mesothelioma patients need more psychosocial support than they are getting, according to a British sociologist. Sara Arber is a…
New Chemo Research: Good and Bad News for Mesothelioma
Three new published studies contain a mixed bag of findings on the effectiveness of chemotherapy for mesothelioma. In a study designed…
Cediranib Fails Phase II Mesothelioma Trial
Some disappointing news for mesothelioma patients and doctors who had high hopes for the chemotherapy drug cediranib. The oral cancer drug, made…